Discounted Cash Flow (DCF) Analysis Unlevered

Novavax, Inc. (NVAX)

$6.875

-0.17 (-2.48%)
All numbers are in Millions, Currency in USD
Stock DCF: -10,730,214.44 | 6.875 | overvalue

Operating Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 34.2918.66475.601,146.291,598.9511,925.8688,949.64663,435.494,948,268.0636,906,914.12
Revenue (%)
EBITDA -173.92-138.61-416.72-1,686.58-633.77-36,358.90-271,184.72-2,022,645.28-15,086,004.80-112,519,749.60
EBITDA (%)
EBIT -182.08-144.29-421.60-1,699.24-662.82-37,746.09-281,531.15-2,099,814.71-15,661,577-116,812,684.71
EBIT (%)
Depreciation 8.165.684.8912.6629.051,387.1910,346.4477,169.43575,572.204,292,935.12
Depreciation (%)

Balance Sheet Data

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 70.1578.82711.051,515.121,336.8823,667.23176,523.291,316,608.139,819,990.0873,242,905.60
Total Cash (%)
Account Receivables -70.327.50262.01454.9982.37-1,549.67-11,558.28-86,208.03-642,987.06-4,795,752.33
Account Receivables (%)
Inventories 11.97-82.97-166.67-1,956.9736.68-14,624.02-109,074.01-813,534.15-6,067,786.70-45,256,901.93
Inventories (%)
Accounts Payable 9.302.9154.33127.05216.521,878.7514,012.77104,514.97779,530.365,814,167.62
Accounts Payable (%)
Capital Expenditure -1.37-1.86-54.62-57.49-92.98-865.04-6,451.94-48,122.09-358,921.14-2,677,031.94
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 6.875
Beta 1.683
Diluted Shares Outstanding 78.18
Cost of Debt
Tax Rate -0.66
After-tax Cost of Debt 3.62%
Risk-Free Rate
Market Risk Premium
Cost of Equity 12.422
Total Debt 549.78
Total Equity 537.51
Total Capital 1,087.29
Debt Weighting 50.56
Equity Weighting 49.44
Wacc

Build Up Free Cash

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 34.2918.66475.601,146.291,598.9511,925.8688,949.64663,435.494,948,268.0636,906,914.12
EBITDA -173.92-138.61-416.72-1,686.58-633.77-36,358.90-271,184.72-2,022,645.28-15,086,004.80-112,519,749.60
EBIT -182.08-144.29-421.60-1,699.24-662.82-37,746.09-281,531.15-2,099,814.71-15,661,577-116,812,684.71
Tax Rate 0.00%1.95%-2.21%-1.70%-0.66%-0.52%-0.52%-0.52%-0.52%-0.52%
EBIAT -182.08-141.47-430.92-1,728.19-667.17-37,943.71-283,005.14-2,110,808.54-15,743,575.02-117,424,271.24
Depreciation 8.165.684.8912.6629.051,387.1910,346.4477,169.43575,572.204,292,935.12
Accounts Receivable --77.82-254.51-192.98372.621,632.0410,008.6174,649.75556,779.034,152,765.27
Inventories -94.9483.711,790.29-1,993.6514,660.7094,449.99704,460.145,254,252.5439,189,115.24
Accounts Payable --6.3951.4272.7289.471,662.2412,134.0290,502.20675,015.385,034,637.27
Capital Expenditure -1.37-1.86-54.62-57.49-92.98-865.04-6,451.94-48,122.09-358,921.14-2,677,031.94
UFCF -175.29-126.93-600.04-102.99-2,262.67-19,466.58-162,518.02-1,212,149.11-9,040,877.01-67,431,850.29
WACC
PV UFCF -18,029.62-139,410.45-963,045.36-6,652,703.31-45,956,777.66
SUM PV UFCF -53,729,966.39

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 7.97
Free cash flow (t + 1) -68,780,487.30
Terminal Value -1,152,101,964.79
Present Value of Terminal Value -785,191,176.12

Intrinsic Value

Enterprise Value -838,921,142.51
Net Debt -787.10
Equity Value -838,920,355.41
Shares Outstanding 78.18
Equity Value Per Share -10,730,214.44